APOE and early-onset autosomal dominant Alzheimer disease: Liposomes functionalized with phosphatidic acid and ApoE-derived peptides have successfully penetrated the BBB, leading to reduced amyloid-beta aggregation and enhanced Alzheimer’s disease therapy [18].